Implementing cognitive services in community pharmacy: A review of facilitators used in practice change

International Journal of Pharmacy Practice

Volumn 14, Issue 3, 2006, Pages 163-170

  Roberts, Alison S ^a   Benrimoj, S I ^a   Chen, Timothy F ^a   Williams, Kylie A ^a   Aslani, Parisa ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; EMPIRICAL RESEARCH; HEALTH SERVICE; HUMAN; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REVIEW;

EID: 33744497136     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.14.3.0002     Document Type: Review

References (61)

1. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of models and frameworks for change. Int J Pharm Pract 2006;14:1-8.
2. Hannan RW, Gans JA, Anthony CJ. Implementing effective change in meeting the demands of community pharmacy practice in the United States. National Association of Chain Drug Stores (NACDS), American Pharmaceutical Association (APhA), National Community Pharmacists Association (NCPA); 1999. www.nacds.org/user-assets/PDF_files/white_paper_pharmacy.pdf (accessed June 8, 2006).
3. Garside P. Organisational context for quality: lessons from the fields of organisational development and change management. Qual Health Care 1998;7(suppl):S8-15.
4. Pendergast JF, Kimberlin CL, Berardo DH, McKenzie LC. Role orientation and community pharmacists' participation in a project to improve patient care. Soc Sci Med 1995;40:557-65.
5. Desselle S. Pharmacists' perceptions of a set of pharmaceutical care practice standards. J Am Pharm Assoc 1997;NS37(5):529-34.
6. Bell HM, McElnay JC, Hughes CM. Societal perspectives on the role of the community pharmacist and community-based pharmaceutical services. J Soc Admin Pharm 2000;17:119-28.
7. Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: A systematic review of the literature 1990-2002. Adelaide: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia; 2003.
8. Donato R, March G, Moss J, Gilbert A. Cost implications of the delivery of pharmaceutical care services through Australian community pharmacies. Int J Pharm Pract 2001;9:23-30.
9. Benrimoj SI, Langford JH, Berry G et al. Economic impact of increased clinical intervention rates in community pharmacy. Pharmacoeconomics 2000;18:459-68.
10. Fincham JE. The role and economic impact of pharmacist care. J Pharm Care 1997;1:1-12.
11. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services - 1988-1995. Pharmacotherapy 1996;16:1188-208.
12. Rovers JP, Currie JD, Hagel HP, McDonough RP, Sobotka JL. Barriers to pharmaceutical care. In: A practical guide to pharmaceutical care. Washington: American Pharmaceutical Association; 1998. pp194-206.
13. Tann J, Blenkinsopp A. Innovation in community pharmacy: Accelerating the spread of change. London: The Pharmacy Practice Research Trust; 2004. www.rpsgb.org.uk/pdfs/innovcommphbrief.pdf (accessed June 7, 2006).
14. Christensen DB, Neil N, Fassett WE et al. Frequency and characteristics of cognitive services provided in response to a financial incentive. J Am Pharm Assoc 2000;40:609-17.
15. Maddux MS, Dong BJ, Miller WA, et al. A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy 2000;20:981-90.
16. Rovers JP, Currie JD, Hagel HP, McDonough RP, Sobotka JL. Creating the infrastructure. In: A practical guide to pharmaceutical care. Washington: American Pharmaceutical Association; 1998. pp207-12.
17. Kotter JP. Leading change: Why transformation efforts fail. Harv Bus Rev 1995;73:59-67.
18. McDonough RP, Pithan ES, Doucette WR, Brownlee MJ. Marketing pharmaceutical care services. J Am Pharm Assoc 1998;38:667-77.
19. Rutter PR, Hunt AJ, Jones IF. Exploring the gap: community pharmacists' perceptions of their current role compared with their aspirations. Int J Pharm Pract 2000;8:204-8.
20. Larson RA. Patients' willingness to pay for pharmaceutical care. J Am Pharm Assoc 2000;40:618-24.
21. Zelnio RN, Nelson AR, Beno CE. Clinical pharmaceutical services in retail practice. I. Pharmacists' willingness and abilities to provide service. Drug Intell Clin Pharm 1984;18:917-22.
22. Nelson Jr AR, Zelnio RN, Beno CE. Clinical pharmaceutical services in retail practice II. Factors influencing the provision of services. Drug Intell Clin Pharm 1984;18:992-6.
23. Ruston A. Achieving re-professionalisation: factors that influence the adoption of an 'extended role' by community pharmacists. A national survey. J Soc Admin Pharm 2001;18:103-10.
24. Miller MJ, Ottmeier BG. Factors influencing the delivery of pharmacy services. J Am Pharm Assoc 1995;NS35:39-44.
25. Kröger E, Moisan J, Gregoire J-P. Billing for cognitive services: understanding Quebec pharmacists' behavior. Ann Pharmacother 2000;34:309-16.
26. Doucette WR, Jambulingam T. Pharmacy entrepreneurial orientation: antecedents and its effect on the provision of innovative pharmacy services. J Soc Admin Pharm 1999;16:26-37.
27. Iyer S, Doucette WR. The influence of environmental attributes on the relationship between entrepreneurial orientation and performance in independent community pharmacies. J Pharm Mark Manage 2003;15:25-46.
28. Odedina FT, Segal R, Hepler C. Providing pharmaceutical care in community practice: differences between providers and non-providers of pharmaceutical care. J Soc Admin Pharm 1995;12:170-80.
29. Tann J, Blenkinsopp A, Allen J, Platts A. Leading edge practitioners in community pharmacy: approaches to innovation. Int J Pharm Pract 1996;4:235-45.
30. Doucette WR, Koch YD. An exploratory study of community pharmacy practice change. J Am Pharm Assoc 2000;40:384-91.
31. Christensen DB, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. J Am Pharm Assoc 1999;39:640-9.
32. Christensen DB, Holmes G, Fassett WE et al. Influence of a financial incentive on cognitive services: CARE project design/implementation. J Am Pharm Assoc 1999;39:629-39.
33. Venkataraman K, Madhavan S, Bone P. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Admin Pharm 1997;14:208-19.
34. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Admin Pharm 1998;15:284-95.
35. Krska J, Veitch GBA. Perceived factors influencing the development of primary care-based pharmaceutical care in Scotland. Int J Pharm Pract 2001;9:243-52.
36. MacRae F, Bennie M, Parr RM, Johnson JR. Factors influencing community pharmacist participation in clinical audit: a qualitative study of barriers and drivers of change. Int J Pharm Pract 2001;9(suppl):R13.
37. Pronk MCM, Blom LTG, Jonkers R, Rogers EM, Bakker A, de Blaey KJ. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World Sci 2002;24:154-61.
38. Rogers EM. Diffusion of Innovations, 4th ed. New York: The Free Press; 1995.
39. Tully MP, Seston EM, Cantrill JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Pract 2000;8:188-97.
40. Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Admin Pharm 2001;19:55-64.
41. Gilbert L. Pharmacy's attempts to extend its roles: A case study in South Africa. Soc Sci Med 1998;47:153-64.
42. Young MD, Stilling WJ, Munger MA. Pharmacy practice Acts: a decade of progress. Ann Pharmacother 1999;33:920-6.
43. Almarsdóttir AB, Morgall JM, Grímsson A. Professional responsibility for patient welfare. Is it possible to legislate pharmaceutical care? J Soc Admin Pharm 2001;18:45-50.
44. Pugh CB. Pre-OBRA '90 Medicaid Survey: How community pharmacy practice is changing. J Am Pharm Assoc 1995;NS35:17-23.
45. Svarstad B, Bultman DC, Mount JK. Patient counselling provided in community pharmacies: Effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc 2004;44:22-9.
46. Perri M, Kotzan J, Pritchard L, Ozburn W, Francisco G. OBRA '90: The impact on pharmacists and patients. J Am Pharm Assoc 1995;NS35:24-65.
47. Barnes JM, Reidlinger JE, McCloskey WW, Montagne M. Barriers to compliance with OBRA '90 regulations in community pharmacies. Ann Pharmacother 1996;30:1101-5.
48. Hepler CD. The future of pharmacy: pharmaceutical care. Am Pharm 1990;NS30:23-9.
49. Phillips S. The role of the community pharmacist: the pharmacist's view. In: Phillips S, Delamont S, Temple D, editors. Qualitative research in pharmacy practice. Aldershot: Ashgate Publishing Ltd; 1996. pp7-22.
50. Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med 1999;49:55-66.
51. Dunphy DC. Organizational change by choice. Sydney: McGraw-Hill; 1981.
52. Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1-72.
53. Bradley EH, Webster TR, Baker D et al. Translating research into practice: speeding the adoption of innovative health care programs. London: The Commonwealth Fund; 2004.
54. Iles V, Sutherland K. Organisational change: a review for health care managers, professionals and researchers. London: National Coordinating Centre for NHS Service Delivery and Organisation R&D; 2001.
55. Johansen IBT. Implementing a pharmaceutical care program in community pharmacies: effects of organizational characteristics on implementation outcomes [PhD]. Madison: University of Wisconsin; 1999.
56. Barner JC, Bennett RW. Pharmaceutical care Certificate Program: assessment of pharmacists' implementation into practice. J Am Pharm Assoc 1999;39:362-7.
57. Berry TM, Ellis MA. Community pharmacists' attitudes towards providing asthma counseling to ambulatory patients. In: ASHP Midyear Clinical Meeting 2003;38:528(E).
58. Munroe WP, Rosenthal TG. Implementing pharmaceutical care: evolution vs revolution. Am Pharm 1994;NS34:57-67.
59. Alves da Costa F, van Mil FJW. Mapping of indicators for successful dissemination of pharmaceutical care. In: PCNE-Europharm Joint Conference; 2004. p44.
60. Bennett J. Increasing interactions with patients in a busy pharmacy. Drug Topics 1997;2 June:130-9.
61. Desselle SP, Tipton DJ. Factors contributing to the satisfaction and performance ability of community pharmacists: a path model analysis. J Soc Admin Pharm 2001;18:15-23.